유럽 ​​지질 패널 테스트 시장 – 2030년까지의 산업 동향 및 예측

TOC 요청 TOC 요청 분석가에게 문의 분석가에게 문의 지금 구매 지금 구매 구매하기 전에 문의 구매하기 전에 문의 무료 샘플 보고서 무료 샘플 보고서

유럽 ​​지질 패널 테스트 시장 – 2030년까지의 산업 동향 및 예측

  • Medical Devices
  • Published Report
  • Mar 2023
  • Europe
  • 350 Pages
  • 테이블 수: 406
  • 그림 수: 39

Europe Lipid Panel Testing Market

시장 규모 (USD 10억)

연평균 성장률 :  % Diagram

Diagram 예측 기간
2024 –2030
Diagram 시장 규모(기준 연도)
백만 달러
Diagram 시장 규모(예측 연도)
미국 달러 4,378.47
Diagram 연평균 성장률
%
Diagram주요 시장 플레이어
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

>유럽 ​​지질 패널 검사 시장, 제품 및 서비스(기기, 키트 및 서비스), 처방 모드(처방 기반 검사 및 OTC 기반 검사), 응용 분야( 고지혈증 , 고중성지방혈증, 가족성 고콜레스테롤혈증, 저지단백혈증, 탕헤르병, 죽상경화증 및 기타), 최종 사용자(병원, 전문 진료소 및 진료실, 병리학 검사실, 진단 진료소, 외래 수술 센터, 참고 검사실, 학술 및 연구 기관 및 기타), 유통 채널(직접 입찰, 소매 약국, 온라인 판매 및 기타) - 업계 동향 및 2030년까지의 예측.

유럽 ​​지질 패널 테스트 시장

유럽 ​​지질 패널 테스트 시장 분석 및 통찰력

유럽의 지질 패널 검사에 대한 인식이 높아짐에 따라 시장 수요가 증가했습니다. 더 나은 건강 서비스를 위한 의료비 지출 증가도 시장 성장에 기여합니다. 주요 시장 참여자들은 이 중요한 기간 동안 다양한 서비스 출시와 승인에 집중합니다. 또한, 프로세스와 기술의 향상된 발전도 지질 패널 검사에 대한 수요 증가에 기여합니다.

유럽 ​​지질 패널 테스트 시장유럽 ​​지질 패널 테스트 시장

유럽 ​​지질 패널 검사 시장은 시장 참여자의 증가와 고급 서비스의 가용성으로 인해 예측 연도에 성장할 것으로 예상됩니다. 이와 함께 제조업체는 시장에서 새로운 서비스와 효율적이고 정확한 지질 패널 검사를 출시하기 위한 개발 활동에 참여하고 있습니다. 고급 의료 기술의 개발이 증가함에 따라 시장 성장이 더욱 촉진되고 있습니다. 그러나 지질 패널 검사 제품의 생산 및 상용화에 대한 엄격한 규정과 같은 어려움이 예측 기간 동안 유럽 지질 패널 검사 시장의 성장을 방해할 수 있습니다.

Data Bridge Market Research에 따르면 유럽 지질 패널 테스트 시장은 2030년까지 43억 7,847만 달러 규모에 도달할 것으로 예상되며, 이는 예측 기간 동안 연평균 성장률 6.7%로 성장할 것으로 예상됩니다.

보고서 메트릭

세부

예측 기간

2023년부터 2030년까지

기준 연도

2022

역사적 연도

2021 (2015-2020까지 사용자 정의 가능)

양적 단위

매출은 백만, 볼륨은 단위, 가격은 USD

다루는 세그먼트

제품 및 서비스(기기, 키트 및 서비스), 처방 모드(처방 기반 테스트 및 OTC 기반 테스트), 애플리케이션(고지혈증, 고중성지방혈증 , 가족성 고콜레스테롤혈증, 저지단백혈증, 탕헤르병, 죽상경화증 및 기타), 최종 사용자(병원, 전문 클리닉 및 의사 사무실, 병리학 실험실, 진단 클리닉, 외래 수술 센터, 참조 실험실, 학술 및 연구 기관 및 기타), 유통 채널(직접 입찰, 소매 약국, 온라인 판매 및 기타)

적용 국가

미국, 캐나다, 멕시코, 독일, 프랑스, ​​영국, 이탈리아, 스페인, 네덜란드, 러시아, 스위스, 유럽의 나머지 지역, 중국, 일본, 인도, 한국, 호주, 싱가포르, 태국, 말레이시아, 인도네시아, 필리핀, 아시아 태평양의 나머지 지역, 브라질, 아르헨티나, 남미의 나머지 지역, 남아프리카, 사우디 아라비아, UAE, 이집트, 이스라엘, 중동 및 아프리카의 나머지 지역

시장 참여자 포함

유럽 ​​지질 패널 검사 시장을 거래하는 몇몇 주요 기업으로는 Nova Biomedical, Spark Diagnostics Pvt. Ltd., Everlywell, Inc., HORIBA Medical, Abbott, F. Hoffmann-La Roche Ltd., SD Biosensor, INC., Elitech Group, Randox Laboratories Ltd., Diatron, Siemens Healthcare GmbH, Sinocare, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., myLAB Box, Awareness Technology, Inc., Croda International Plc., Eurofins Scientific, Boston Heart Diagnostics Corporation, cpc diagnostics, PTS Diagnostics, ARUP Laboratories, Laboratory Corporation of America Holdings, EKF Diagnostics, Beckman Coulter, Inc. (Danaher 자회사), Sekisui Diagnostics (SEKISUI Chemical Co. Ltd.의 일부) 등이 있습니다.

유럽 ​​지질 패널 테스트 시장 정의

지질 패널은 의료 서비스 제공자가 심혈관 질환 위험을 모니터링하고 선별하는 데 사용하는 일반적인 혈액 검사입니다. 이 패널에는 콜레스테롤 측정 3가지와 트리글리세리드 측정이 포함됩니다.

의료 서비스 제공자는 지질 패널을 사용하여 혈액 내 콜레스테롤을 분석하여 누군가의 심혈관 건강을 평가하고 다른 건강 상태를 진단하는 데 도움을 줍니다. 지질 패널은 혈액 내 지질로 알려진 특정 지방 분자의 존재를 평가합니다. 여러 콜레스테롤 함유 분자를 포함하여 패널 테스트로 여러 물질을 측정합니다. 지질 패널은 어린이와 성인의 심장병, 심장마비, 뇌졸중과 같은 심혈관 질환의 위험을 평가합니다.

유럽 ​​지질 패널 테스트 시장 동향

이 섹션에서는 시장 동인, 이점, 기회, 제약 및 과제를 이해하는 것을 다룹니다. 이 모든 내용은 아래에서 자세히 설명합니다.    

운전자

  • 만성 질환의 유병률 증가

지질 패널은 의료 서비스 제공자가 심혈관 질환 및 기타 만성 질환의 위험을 모니터링하고 선별하는 데 사용하는 일반적인 혈액 검사입니다. 이 패널에는 콜레스테롤 측정 3회와 트리글리세리드 측정이 포함됩니다. 제공자와 의료 전문가는 대부분 지질 패널을 사용하여 콜레스테롤 수치를 선별하거나 모니터링합니다. 제공자는 때때로 췌장염, 만성 신장 질환 및 갑상선 기능 저하증을 포함하여 지질 수치에 영향을 미칠 수 있는 특정 건강 상태에 대한 진단 과정의 일부로 이를 사용합니다.

따라서 결론적으로 심혈관 질환, 만성 신장 질환, 간 질환 및 기타 만성 질환의 증가로 인해 지질 프로파일링에 대한 수요가 증가했으며 지질 패널 검사 키트에 대한 시장 수요가 증가함에 따라 향후 몇 년 동안 유럽 지질 패널 검사 시장이 성장할 것입니다.

제지

  • 테스트 패널과 관련된 높은 비용

지질 프로필 검사는 지질 패널, 콜레스테롤 프로필 또는 심장 위험 프로필입니다. 이것은 콜레스테롤과 트리글리세리드와 같은 혈액 지방 수치를 측정하는 데 도움이 되는 혈액 검사의 조합입니다. 이러한 콜레스테롤과 트리글리세리드는 좋은 유형의 지방과 나쁜 유형의 지방입니다.

테스트 패널은 개발 프로세스에 막대한 비용이 필요합니다. 컨셉을 확정해야 하므로 재료를 조달해야 하며 리드 타임을 고려하는 것이 중요합니다. 또한, 기기 설계가 시장에 출시되기 전에 완전히 성숙할 수 있는 충분한 시간이 필요하기 때문에 프로세스가 시간이 많이 걸립니다.

또한, 재검증해야 하는 변경 사항은 시간에 영향을 미칩니다. 바이오센서 분석 형식과 기타 보완 기술의 발전으로 성공적인 운영을 위한 효과적인 투자와 프로젝트 위험 관리 계획이 필요했습니다. 연구를 수행하기 위한 R&D를 구축하는 데는 많은 비용이 수반되어 값비싼 장치가 필요합니다. 따라서 이 요인은 유럽 지질 패널 테스트 시장의 주요 제약입니다.

기회

기술 발전의 성장

지질 패널은 의료 서비스 제공자가 심혈관 질환 위험을 모니터링하고 선별하는 데 사용하는 일반적인 혈액 검사입니다. 이 패널에는 콜레스테롤 측정 3가지와 트리글리세리드 측정이 포함됩니다.

지질 패널 검사의 기술적 발전은 다양한 지질 패널 검사에 사용되는 방식에 따라 정확도, 민감도, 성공률, 새로운 소재를 추가로 향상시킵니다. 진단 및 검사 절차에 사용되는 첨단 기술 기반 지질 패널 검사 장치와 제품의 상용화는 소비자 수요를 증가시켜 시장 수요를 촉진합니다.

따라서 지질 패널 시험 방법의 기술적 진보와 개발은 유럽 지질 패널 시험 시장의 성장을 촉진할 것으로 예상됩니다.

도전

숙련되고 인증된 전문가의 부족  

숙련되고 인증된 전문가에 대한 요구는 지질 패널 검사에 큰 과제입니다. 비만, 심혈관 질환 및 콜레스테롤 유럽의 증가로 인해 진단을 위한 지질 패널 검사에 대한 수요가 증가하고 있습니다. 그러나 진단 센터의 숙련된 전문가가 적기 때문에 시장 성장이 방해받고 있습니다.

지질 패널 검사 진단의 도구, 방법 및 절차는 발전했지만 표준화, 평등화 및 지식에 일정한 격차가 있습니다. 기술자는 문제와 관련된 기술 교육 격차에 직면하고 고급 방법을 안전하게 적용하여 절차를 효율적으로 수행합니다. 지질 패널 검사에서 방법 개발, 검증, 운영 및 문제 해결을 위해 숙련된 전문가가 매우 필요합니다.

유럽 ​​지질 패널 테스트 시장에 대한 COVID-19 이후 영향 분석

코로나19는 2020년 초부터 환자 수가 급격히 감소하면서 진단 분야에 큰 타격을 입혔습니다. 이 팬데믹은 사람들 사이에 섬뜩한 공포감을 조성했고, 결국 병원/클리닉과 실험실 방문에 영향을 미쳤습니다. 정기 검진은 번거롭고 스트레스가 많고 시간이 많이 걸렸습니다. 전반적인 진단 분야가 쇠퇴한 것처럼 보였지만, 가정 진단 분야는 새로운 계획에서 희망의 빛이었습니다.

최근 개발 사항

  • 2022년 10월, Eurofins Scientific은 플랑드르 정부의 건강 및 보건 기관에서 의뢰한 혈액 안트렙의 PFAS(폴리플루오로알킬)에 대한 가장 큰 유럽 생물 모니터링 프로젝트의 시작을 발표했습니다. 이 제품 출시는 회사의 제품 포트폴리오 확장에 도움이 되었습니다.
  • 2022년 12월, Laboratory Corporation of America Holdings는 로스앤젤레스에 있는 새롭고 더 큰 해부병리학 및 조직학 실험실에서 운영을 시작했다고 발표했습니다. 이 새로운 운영은 회사가 유럽 중앙 실험실 역량을 확장하는 데 도움이 되었습니다.

유럽 ​​지질 패널 테스트 시장 범위

유럽 ​​지질 패널 테스트 시장은 제품 및 서비스, 처방 모드, 애플리케이션, 최종 사용자 및 유통 채널과 같은 5가지 주요 세그먼트로 세분화됩니다. 세그먼트 간의 성장은 틈새 성장 포켓과 시장에 접근하고 핵심 애플리케이션 영역과 타겟 시장의 차이점을 파악하기 위한 전략을 분석하는 데 도움이 됩니다.  

제품 및 서비스

  •  장치
  • 키트
  • 서비스

유럽 ​​지질 패널 검사 시장은 제품과 서비스를 기준으로 장비, 키트, 서비스로 구분됩니다.

처방 모드

  • 처방 기반 테스트
  • OTC 기반 테스트

유럽 ​​지질 패널 시험 시장은 처방 방식을 기준으로 처방 기반 시험과 OTC 기반 시험으로 구분됩니다.

애플리케이션

  • 고지혈증
  • 고트리글리세리드혈증
  • 가족성 고콜레스테롤혈증
  • 저지방단백혈증
  • 탕헤르 질병
  • 동맥경화증
  • 기타

유럽 ​​지질 패널 검사 시장은 응용 프로그램을 기준으로 고지혈증, 고중성지방혈증, 가족성 고콜레스테롤혈증, 저지단백혈증, 탕헤르 질환, 죽상경화증 및 기타로 구분됩니다.

최종 사용자

  • 병원
  • 전문 진료소 및 의사 사무실
  • 병리학 실험실
  • 진단 클리닉
  • 외래 수술 센터
  • 참조 연구실
  • 학술 및 연구 기관
  • 기타

유럽 ​​지질 패널 검사 시장은 최종 사용자를 기준으로 병원, 전문 진료소 및 의사 진료소, 병리학 실험실, 진단 진료소, 외래 수술 센터, 표준 실험실, 학술 및 연구 기관 등으로 구분됩니다.

유통 채널

  • 직접 입찰
  • 소매 약국
  • 온라인 판매
  • 기타

유럽 ​​지질 패널 검사 시장은 유통 채널을 기준으로 직접 입찰, 소매 약국, 온라인 판매 및 기타로 구분됩니다.

지질 패널 테스트 시장

유럽 ​​지질 패널 테스트 시장 지역 분석/통찰력

유럽 ​​지질 패널 테스트 시장은 제품 및 서비스, 처방 모드, 애플리케이션, 최종 사용자, 유통 채널의 5가지 주요 부문으로 분류됩니다.

이 시장 보고서에서 다루는 국가는 독일, 프랑스, ​​영국, 이탈리아, 스페인, 터키, 네덜란드, 러시아, 스위스, 그리고 나머지 유럽 국가입니다.

영국은 신흥시장의 수요 증가와 확장으로 인해 유럽 지역에서 우위를 점하고 있습니다.

보고서의 국가 섹션은 또한 개별 시장 영향 요인과 국내 시장의 현재 및 미래 트렌드에 영향을 미치는 규제 변화를 제공합니다. 신규 판매, 교체 판매, 국가 인구 통계, 규제 조치 및 수출입 관세와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 주요 포인터 중 일부입니다. 또한 유럽 브랜드의 존재 및 가용성과 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 판매 채널의 영향이 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.

경쟁 환경 및 유럽 지질 패널 테스트 시장 점유율 분석

유럽 ​​지질 패널 테스트 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, R&D 투자, 새로운 시장 이니셔티브, 생산 현장 및 시설, 회사의 강점과 약점, 제품 출시, 제품 승인, 제품 폭 및 호흡, 응용 프로그램 우세, 제품 유형 수명선 곡선입니다. 위에 제공된 데이터 포인트는 유럽 지질 패널 테스트 시장에 대한 회사의 초점과만 관련이 있습니다.

유럽 ​​지질 패널 검사 시장에서 거래하는 주요 기업으로는 Nova Biomedical, Spark Diagnostics Pvt. Ltd., Everlywell, Inc., HORIBA Medical, Abbott, F. Hoffmann-La Roche Ltd., SD Biosensor, INC., Elitech Group, Randox Laboratories Ltd., Diatron, Siemens Healthcare GmbH, Sinocare, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., myLAB Box, Awareness Technology, Inc., Croda International Plc., Eurofins Scientific, Boston Heart Diagnostics Corporation, cpc diagnostics, PTS Diagnostics, ARUP Laboratories, Laboratory Corporation of America Holdings, EKF Diagnostics, Beckman Coulter, Inc. (Danaher 자회사), Sekisui Diagnostics (SEKISUI Chemical Co. Ltd.의 일부) 등이 있습니다.


SKU-

세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요

  • 대화형 데이터 분석 대시보드
  • 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
  • 사용자 정의 및 질의를 위한 리서치 분석가 액세스
  • 대화형 대시보드를 통한 경쟁자 분석
  • 최신 뉴스, 업데이트 및 추세 분석
  • 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
데모 요청

목차

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE EUROPE LIPID PANEL TESTING MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 PRODUCTS & SERVICES LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.1 MARKET TESTING TYPE COVERAGE GRID

2.11 VENDOR SHARE ANALYSIS

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTEL ANALYSIS

4.2 PORTER’S FIVE FORCES

4.3 PATENT ANALYSIS

5 INDUSTRIAL INSIGHTS

5.1 KEY PRICING STRATEGY

6 EUROPE LIPID PANEL TESTING MARKET, REGULATIONS

6.1 REGULATORY SCENARIO IN EUROPE

7 MARKET OVERVIEW

7.1 DRIVERS

7.1.1 INCREASING PREVALENCE OF CHRONIC DISEASES

7.1.2 GROWING NUMBER OF CASES OF DYSLIPIDEMIA

7.1.3 RAPID CHANGES IN LIFESTYLE CHANGES LEAD TO LIPID DISORDERS

7.1.4 RISE IN PREFERENCE FOR HOMECARE TESTING IN LIPID PANEL TESTING

7.2 RESTRAINTS

7.2.1 STRICT GOVERNMENT REGULATIONS

7.2.2 HIGH COST ASSOCIATED WITH TESTING PANELS

7.3 OPPORTUNITIES

7.3.1 GROWTH IN TECHNOLOGICAL ADVANCEMENTS

7.3.2 RISE IN THE PREVALENCE OF OBESITY AMONG PEOPLE

7.3.3 INCREASING ADOPTION OF POINT-OF-CARE LIPID PANEL TESTING

7.4 CHALLENGES

7.4.1 LACK OF SKILLED & CERTIFIED PROFESSIONALS

7.4.2 LACK OF STANDARDIZATION OF LIPID PANEL TESTING

8 EUROPE LIPID PANEL TESTING MARKET, BY PRODUCTS & SERVICES

8.1 OVERVIEW

8.2 SERVICES

8.2.1 LOW DENSITY LIPOPROTEIN (LDL) TEST

8.2.2 TOTAL CHOLESTEROL TEST

8.2.3 HIGH DENSITY LIPOPROTEIN (HDL) TEST

8.2.4 TRIGLYCERIDES/ VLDL TEST

8.2.5 NON-HDL CHOLESTEROL TEST

8.2.6 OTHERS

8.3 KITS

8.3.1 STRIPS

8.3.1.1 THREE-ANALYTE TEST STRIPS

8.3.1.2 DUAL-ANALYTE TEST STRIPS

8.3.1.3 SINGLE-ANALYTE TEST STRIPS

8.3.2 LANCETS

8.3.3 CONTROLS

8.3.3.1 MULTI-CHEMISTRY CONTROLS

8.3.3.2 HDL CHOLESTEROL CONTROLS

8.3.3.3 OTHERS

8.3.4 CAPILLARY TUBES

8.4 DEVICES

8.4.1 BY MODALITY

8.4.1.1 STANDALONE

8.4.1.2 HANDHELD

8.4.1.3 PORTABLE

8.4.2 BY TYPE

8.4.2.1 LABORATORY BASED

8.4.2.2 POINT OF CARE BASED

9 EUROPE LIPID PANEL TESTING MARKET, BY PRESCRIPTION MODE

9.1 OVERVIEW

9.2 PRESCRIPTION-BASED TESTING

9.3 OTC-BASED TESTING

10 EUROPE LIPID PANEL TESTING MARKET, BY APPLICATION

10.1 OVERVIEW

10.2 HYPERLIPIDEMIA

10.2.1 TOTAL CHOLESTEROL TEST

10.2.2 TRIGLYCERIDES/ VLDL TEST

10.2.3 LOW DENSITY LIPOPROTEIN (LDL) TEST

10.2.4 HIGH DENSITY LIPOPROTEIN (HDL) TEST

10.2.5 NON-HDL CHOLESTEROL TEST

10.2.6 OTHERS

10.3 HYPERTRIGLYCERIDEMIA

10.3.1 TRIGLYCERIDES/ VLDL TEST

10.3.2 TOTAL CHOLESTEROL TEST

10.3.3 LOW DENSITY LIPOPROTEIN (LDL) TEST

10.3.4 HIGH DENSITY LIPOPROTEIN (HDL) TEST

10.3.5 NON-HDL CHOLESTEROL TEST

10.3.6 OTHERS

10.4 ATHEROSCLEROSIS

10.4.1 LOW DENSITY LIPOPROTEIN (LDL) TEST

10.4.2 TOTAL CHOLESTEROL TEST

10.4.3 TRIGLYCERIDES/ VLDL TEST

10.4.4 HIGH DENSITY LIPOPROTEIN (HDL) TEST

10.4.5 NON-HDL CHOLESTEROL TEST

10.4.6 OTHERS

10.5 FAMILIAL HYPERCHOLESTEROLEMIA

10.5.1 LOW DENSITY LIPOPROTEIN (LDL) TEST

10.5.2 TOTAL CHOLESTEROL TEST

10.5.3 HIGH DENSITY LIPOPROTEIN (HDL) TEST

10.5.4 TRIGLYCERIDES/ VLDL TEST

10.5.5 NON-HDL CHOLESTEROL TEST

10.5.6 OTHERS

10.6 HYPO LIPOPROTEINEMIA

10.6.1 LOW DENSITY LIPOPROTEIN (LDL) TEST

10.6.2 HIGH DENSITY LIPOPROTEIN (HDL) TEST

10.6.3 TRIGLYCERIDES/ VLDL TEST

10.6.4 TOTAL CHOLESTEROL TEST

10.6.5 NON-HDL CHOLESTEROL TEST

10.6.6 OTHERS

10.7 TANGIER DISEASE

10.7.1 HIGH DENSITY LIPOPROTEIN (HDL) TEST

10.7.2 LOW DENSITY LIPOPROTEIN (LDL) TEST

10.7.3 TOTAL CHOLESTEROL TEST

10.7.4 TRIGLYCERIDES/ VLDL TEST

10.7.5 NON-HDL CHOLESTEROL TEST

10.7.6 OTHERS

10.8 OTHERS

11 EUROPE LIPID PANEL TESTING MARKET, BY END USER

11.1 OVERVIEW

11.2 HOSPITAL

11.2.1 BY TYPE

11.2.1.1 PRIVATE

11.2.1.1.1 SERVICES

11.2.1.1.2 KITS

11.2.1.1.3 DEVICES

11.2.1.2 PUBLIC

11.2.1.2.1 SERVICES

11.2.1.2.2 KITS

11.2.1.2.3 DEVICES

11.2.2 BY TIER

11.2.2.1 TIER 1

11.2.2.1.1 SERVICES

11.2.2.1.2 KITS

11.2.2.1.3 DEVICES

11.2.2.2 TIER 2

11.2.2.2.1 SERVICES

11.2.2.2.2 KITS

11.2.2.2.3 DEVICES

11.2.2.3 TIER 3

11.2.2.3.1 SERVICES

11.2.2.3.2 KITS

11.2.2.3.3 DEVICES

11.3 DIAGNOSTIC CLINICS

11.3.1 SERVICES

11.3.2 KITS

11.3.3 DEVICES

11.4 SPECIALTY CLINICS & PHYSICIAN OFFICES

11.4.1 SERVICES

11.4.2 KITS

11.4.3 DEVICES

11.5 REFERENCE LABORATORIES

11.5.1 SERVICES

11.5.2 KITS

11.5.3 DEVICES

11.6 AMBULATORY SURGICAL CENTERS

11.6.1 SERVICES

11.6.2 KITS

11.6.3 DEVICES

11.7 PATHOLOGY LABORATORIES

11.7.1 SERVICES

11.7.2 KITS

11.7.3 DEVICES

11.8 ACADEMIC AND RESEARCH INSTITUTES

11.8.1 SERVICES

11.8.2 KITS

11.8.3 DEVICES

11.9 OTHERS

12 EUROPE LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL

12.1 OVERVIEW

12.2 DIRECT TENDER

12.3 RETAIL PHARMACY

12.3.1 HOSPITAL PHARMACIES

12.3.2 DRUG STORES

12.3.3 OTHERS

12.4 ONLINE SALES

12.5 OTHERS

13 EUROPE LIPID PANEL TESTING MARKET, BY REGION

13.1 EUROPE

13.1.1 U.K.

13.1.2 GERMANY

13.1.3 FRANCE

13.1.4 RUSSIA

13.1.5 ITALY

13.1.6 SPAIN

13.1.7 TURKEY

13.1.8 NETHERLANDS

13.1.9 SWITZERLAND

13.1.10 REST OF EUROPE

14 EUROPE LIPID PANEL TESTING MARKET, COMPANY LANDSCAPE

14.1 COMPANY SHARE ANALYSIS: EUROPE

15 SWOT ANALYSIS

16 EUROPE LIPID PANEL TESTING MARKET, COMPANY PROFILE

16.1 QUEST DIAGNOSTICS INCORPORATED

16.1.1 COMPANY SNAPSHOT

16.1.2 REVENUE ANALYSIS

16.1.3 COMPANY SHARE ANALYSIS

16.1.4 PRODUCT PORTFOLIO

16.1.5 RECENT DEVELOPMENTS

16.2 EUROFINS SCIENTIFIC

16.2.1 COMPANY SNAPSHOT

16.2.2 REVENUE ANALYSIS

16.2.3 COMPANY SHARE ANALYSIS

16.2.4 PRODUCT PORTFOLIO

16.2.5 RECENT DEVELOPMENT

16.3 LABORATORY CORPORATION OF AMERICA HOLDINGS

16.3.1 COMPANY SNAPSHOT

16.3.2 REVENUE ANALYSIS

16.3.3 COMPANY SHARE ANALYSIS

16.3.4 PRODUCT PORTFOLIO

16.3.5 RECENT DEVELOPMENT

16.4 F. HOFFMANN-LA ROCHE LTD.

16.4.1 COMPANY SNAPSHOT

16.4.2 REVENUE ANALYSIS

16.4.3 COMPANY SHARE ANALYSIS

16.4.4 PRODUCT PORTFOLIO

16.4.5 RECENT DEVELOPMENT

16.5 RANDOX LABORATORIES LTD.

16.5.1 COMPANY SNAPSHOT

16.5.2 COMPANY SHARE ANALYSIS

16.5.3 PRODUCT PORTFOLIO

16.5.4 RECENT DEVELOPMENT

16.6 ABBOTT

16.6.1 COMPANY SNAPSHOT

16.6.2 REVENUE ANALYSIS

16.6.3 COMPANY SHARE ANALYSIS

16.6.4 PRODUCT PORTFOLIO

16.6.5 RECENT DEVELOPMENT

16.7 AWARENESS TECHNOLOGY, INC.

16.7.1 COMPANY SNAPSHOT

16.7.2 PRODUCT PORTFOLIO

16.7.3 RECENT DEVELOPMENTS

16.8 ARUP LABORATORIES

16.8.1 COMPANY SNAPSHOT

16.8.2 PRODUCT PORTFOLIO

16.8.3 RECENT DEVELOPMENT

16.9 BIO-RAD LABORATORIES, INC.

16.9.1 COMPANY SNAPSHOT

16.9.2 REVENUE ANALYSIS

16.9.3 PRODUCT PORTFOLIO

16.9.4 RECENT DEVELOPMENT

16.1 BECKMAN COULTER, INC. (SUBSIDIARY OF DANAHER)

16.10.1 COMPANY SNAPSHOT

16.10.2 REVENUE ANALYSIS

16.10.3 PRODUCT PORTFOLIO

16.10.4 RECENT DEVELOPMENT

16.11 BOSTON HEART DIAGNOSTICS CORPORATION

16.11.1 COMPANY SNAPSHOT

16.11.2 PRODUCT PORTFOLIO

16.11.3 RECENT DEVELOPMENT

16.12 CPC DIAGNOSTICS

16.12.1 COMPANY SNAPSHOT

16.12.2 PRODUCT PORTFOLIO

16.12.3 RECENT DEVELOPMENT

16.13 CRODA INTERNATIONAL PLC.

16.13.1 COMPANY SNAPSHOT

16.13.2 REVENUE ANALYSIS

16.13.3 PRODUCT PORTFOLIO

16.13.4 RECENT DEVELOPMENT

16.14 DIATRON

16.14.1 COMPANY SNAPSHOT

16.14.2 PRODUCT PORTFOLIO

16.14.3 RECENT DEVELOPMENT

16.15 EKF DIAGNOSTICS

16.15.1 COMPANY SNAPSHOT

16.15.2 REVENUE ANALYSIS

16.15.3 PRODUCT PORTFOLIO

16.15.4 RECENT DEVELOPMENT

16.16 EVERLYWELL, INC.

16.16.1 COMPANY SNAPSHOT

16.16.2 PRODUCT PORTFOLIO

16.16.3 RECENT DEVELOPMENT

16.17 ELITECH GROUP

16.17.1 COMPANY SNAPSHOT

16.17.2 PRODUCT PORTFOLIO

16.17.3 RECENT DEVELOPMENT

16.18 HORIBA MEDICAL

16.18.1 COMPANY SNAPSHOT

16.18.2 REVENUE ANALYSIS

16.18.3 PRODUCT PORTFOLIO

16.18.4 RECENT DEVELOPMENT

16.19 MYLAB BOX

16.19.1 COMPANY SNAPSHOT

16.19.2 PRODUCT PORTFOLIO

16.19.3 RECENT DEVELOPMENT

16.2 NOVA BIOMEDICAL

16.20.1 COMPANY SNAPSHOT

16.20.2 PRODUCT PORTFOLIO

16.20.3 RECENT DEVELOPMENT

16.21 PTS DIAGNOSTICS

16.21.1 COMPANY SNAPSHOT

16.21.2 PRODUCT PORTFOLIO

16.21.3 RECENT DEVELOPMENT

16.22 SIEMENS HEALTHCARE GMBH

16.22.1 COMPANY SNAPSHOT

16.22.2 REVENUE ANALYSIS

16.22.3 PRODUCT PORTFOLIO

16.22.4 RECENT DEVELOPMENT

16.23 SINOCARE

16.23.1 COMPANY SNAPSHOT

16.23.2 REVENUE ANALYSIS

16.23.3 PRODUCT PORTFOLIO

16.23.4 RECENT DEVELOPMENT

16.24 SD BIOSENSOR, INC.

16.24.1 COMPANY SNAPSHOT

16.24.2 REVENUE ANALYSIS

16.24.3 PRODUCT PORTFOLIO

16.24.4 RECENT DEVELOPMENT

16.25 SEKISUI DIAGNOSTICS (A PART OF SEKISUI CHEMICAL CO. LTD.)

16.25.1 COMPANY SNAPSHOT

16.25.2 REVENUE ANALYSIS

16.25.3 PRODUCT PORTFOLIO

16.25.4 RECENT DEVELOPMENTS

16.26 SPARK DIAGNOSTICS PVT. LTD.

16.26.1 COMPANY SNAPSHOT

16.26.2 PRODUCT PORTFOLIO

16.26.3 RECENT DEVELOPMENTS

16.27 THERMO FISHER SCIENTIFIC INC.

16.27.1 COMPANY SNAPSHOT

16.27.2 REVENUE ANALYSIS

16.27.3 PRODUCT PORTFOLIO

16.27.4 RECENT DEVELOPMENT

17 QUESTIONNAIRE

18 RELATED REPORTS

표 목록

TABLE 1 THE BELOW-MENTIONED TABLE SHOWS THE COST OF VARIOUS LIPID PANEL TESTING DEVICES OFFERED BY DIFFERENT MANUFACTURERS-

TABLE 2 EUROPE LIPID PANEL TESTING MARKET, BY PRODUCTS & SERVICES, 2021-2030 (USD MILLION)

TABLE 3 EUROPE SERVICES IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 4 EUROPE SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)

TABLE 5 EUROPE KITS IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 6 EUROPE KITS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 7 EUROPE STRIPS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 8 EUROPE CONTROLS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 9 EUROPE DEVICES IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 10 EUROPE DEVICES IN LIPID PANEL TESTING MARKET, BY MODALITY, 2021-2030 (USD MILLION)

TABLE 11 EUROPE DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 12 EUROPE LIPID PANEL TESTING MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)

TABLE 13 EUROPE PRESCRIPTION-BASED TESTING IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 14 EUROPE OTC-BASED TESTING IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 15 EUROPE LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 16 EUROPE HYPERLIPIDEMIA IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 17 EUROPE HYPERLIPIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 18 EUROPE HYPERTRIGLYCERIDEMIA IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 19 EUROPE HYPERTRIGLYCERIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 20 EUROPE ATHEROSCLEROSIS IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 21 EUROPE ATHEROSCLEROSIS IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 22 EUROPE FAMILIAL HYPERCHOLESTEROLEMIA IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 23 EUROPE FAMILIAL HYPERCHOLESTEROLEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 24 EUROPE HYPO LIPOPROTEINEMIA IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 25 EUROPE HYPO LIPOPROTEINEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 26 EUROPE TANGIER DISEASE IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 27 EUROPE TANGIER DISEASE IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 28 EUROPE OTHERS IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 29 EUROPE LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 30 EUROPE HOSPITAL IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 31 EUROPE HOSPITAL IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 32 EUROPE PRIVATE IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 33 EUROPE PUBLIC IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 34 EUROPE HOSPITAL IN LIPID PANEL TESTING MARKET, BY TIER, 2021-2030 (USD MILLION)

TABLE 35 EUROPE TIER 1 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 36 EUROPE TIER 2 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 37 EUROPE TIER 3 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 38 EUROPE DIAGNOSTIC CLINICS IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 39 EUROPE DIAGNOSTIC CLINICS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 40 EUROPE SPECIALTY CLINICS & PHYSICIAN OFFICES IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 41 EUROPE SPECIALTY CLINICS & PHYSICIAN OFFICES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 42 EUROPE REFERENCE LABORATORIES IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 43 EUROPE REFERENCE LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 44 EUROPE AMBULATORY SURGICAL CENTERS IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 45 EUROPE AMBULATORY SURGICAL CENTERS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 46 EUROPE PATHOLOGY LABORATORIES IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 47 EUROPE PATHOLOGY LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 48 EUROPE ACADEMIC AND RESEARCH INSTITUTES IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 49 EUROPE ACADEMIC AND RESEARCH INSTITUTES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 50 EUROPE OTHERS IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 51 EUROPE LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 52 EUROPE DIRECT TENDER IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 53 EUROPE RETAIL PHARMACY IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 54 EUROPE RETAIL PHARMACY IN LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 55 EUROPE ONLINE SALES IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 56 EUROPE OTHERS IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 57 EUROPE LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 58 EUROPE DEVICES IN LIPID PANEL TESTING MARKET, BY REGION, 2021-2030 (USD MILLION)

TABLE 59 EUROPE SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)

TABLE 60 EUROPE SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (NUMBER OF TESTS)

TABLE 61 EUROPE KITS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 62 EUROPE STRIPS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 63 EUROPE CONTROLS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 64 EUROPE DEVICES IN LIPID PANEL TESTING MARKET, BY MODALITY, 2021-2030 (USD MILLION)

TABLE 65 EUROPE DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 66 EUROPE DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (UNITS)

TABLE 67 EUROPE LIPID PANEL TESTING MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)

TABLE 68 EUROPE LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 69 EUROPE HYPERLIPIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 70 EUROPE HYPERTRIGLYCERIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 71 EUROPE ATHEROSCLEROSIS IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 72 EUROPE FAMILIAL HYPERCHOLESTEROLEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 73 EUROPE HYPO LIPOPROTEINAMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 74 EUROPE TANGIER DISEASE IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 75 EUROPE LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 76 EUROPE HOSPITAL IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 77 EUROPE PRIVATE IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 78 EUROPE PUBLIC IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 79 EUROPE HOSPITAL IN LIPID PANEL TESTING MARKET, BY TIER, 2021-2030 (USD MILLION)

TABLE 80 EUROPE TIER 1 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 81 EUROPE TIER 2 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 82 EUROPE TIER 3 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 83 EUROPE DIAGNOSTIC CLINICS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 84 EUROPE SPECIALTY CLINICS AND PHYSICIAN OFFICES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 85 EUROPE REFERENCE LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 86 EUROPE AMBULATORY SURGICAL CENTERS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 87 EUROPE PATHOLOGY LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 88 EUROPE ACADEMIC AND RESEARCH INSTITUTES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 89 EUROPE LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 90 EUROPE RETAIL PHARMACY IN LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 91 U.K. LIPID PANEL TESTING MARKET, BY PRODUCTS AND SERVICES, 2021-2030 (USD MILLION)

TABLE 92 U.K. SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)

TABLE 93 U.K. SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (PRICE PER TEST)

TABLE 94 U.K. SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (NUMBER OF TESTS)

TABLE 95 U.K. KITS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 96 U.K. STRIPS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 97 U.K. CONTROLS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 98 U.K. DEVICES IN LIPID PANEL TESTING MARKET, BY MODALITY, 2021-2030 (USD MILLION)

TABLE 99 U.K. DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 100 U.K. DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 ASP

TABLE 101 U.K. DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (UNITS)

TABLE 102 U.K. LIPID PANEL TESTING MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)

TABLE 103 U.K. LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 104 U.K. HYPERLIPIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 105 U.K. HYPERTRIGLYCERIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 106 U.K. ATHEROSCLEROSIS IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 107 U.K. FAMILIAL HYPERCHOLESTEROLEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 108 U.K. HYPO LIPOPROTEINAMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 109 U.K. TANGIER DISEASE IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 110 U.K. LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 111 U.K. HOSPITAL IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 112 U.K. PRIVATE IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 113 U.K. PUBLIC IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 114 U.K. HOSPITAL IN LIPID PANEL TESTING MARKET, BY TIER, 2021-2030 (USD MILLION)

TABLE 115 U.K. TIER 1 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 116 U.K. TIER 2 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 117 U.K. TIER 3 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 118 U.K. DIAGNOSTIC CLINICS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 119 U.K. SPECIALTY CLINICS AND PHYSICIAN OFFICES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 120 U.K. REFERENCE LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 121 U.K. AMBULATORY SURGICAL CENTERS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 122 U.K. PATHOLOGY LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 123 U.K. ACADEMIC AND RESEARCH INSTITUTES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 124 U.K. LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 125 U.K. RETAIL PHARMACY IN LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 126 GERMANY LIPID PANEL TESTING MARKET, BY PRODUCTS AND SERVICES, 2021-2030 (USD MILLION)

TABLE 127 GERMANY SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)

TABLE 128 GERMANY SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (PRICE PER TEST)

TABLE 129 GERMANY SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (NUMBER OF TESTS)

TABLE 130 GERMANY KITS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 131 GERMANY STRIPS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 132 GERMANY CONTROLS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 133 GERMANY DEVICES IN LIPID PANEL TESTING MARKET, BY MODALITY, 2021-2030 (USD MILLION)

TABLE 134 GERMANY DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 135 GERMANY DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 ASP

TABLE 136 GERMANY DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (UNITS)

TABLE 137 GERMANY LIPID PANEL TESTING MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)

TABLE 138 GERMANY LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 139 GERMANY HYPERLIPIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 140 GERMANY HYPERTRIGLYCERIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 141 GERMANY ATHEROSCLEROSIS IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 142 GERMANY FAMILIAL HYPERCHOLESTEROLEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 143 GERMANY HYPO LIPOPROTEINAMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 144 GERMANY TANGIER DISEASE IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 145 GERMANY LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 146 GERMANY HOSPITAL IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 147 GERMANY PRIVATE IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 148 GERMANY PUBLIC IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 149 GERMANY HOSPITAL IN LIPID PANEL TESTING MARKET, BY TIER, 2021-2030 (USD MILLION)

TABLE 150 GERMANY TIER 1 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 151 GERMANY TIER 2 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 152 GERMANY TIER 3 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 153 GERMANY DIAGNOSTIC CLINICS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 154 GERMANY SPECIALTY CLINICS AND PHYSICIAN OFFICES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 155 GERMANY REFERENCE LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 156 GERMANY AMBULATORY SURGICAL CENTERS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 157 GERMANY PATHOLOGY LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 158 GERMANY ACADEMIC AND RESEARCH INSTITUTES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 159 GERMANY LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 160 GERMANY RETAIL PHARMACY IN LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 161 FRANCE LIPID PANEL TESTING MARKET, BY PRODUCTS AND SERVICES, 2021-2030 (USD MILLION)

TABLE 162 FRANCE SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)

TABLE 163 FRANCE SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (PRICE PER TEST)

TABLE 164 FRANCE SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (NUMBER OF TESTS)

TABLE 165 FRANCE KITS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 166 FRANCE STRIPS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 167 FRANCE CONTROLS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 168 FRANCE DEVICES IN LIPID PANEL TESTING MARKET, BY MODALITY, 2021-2030 (USD MILLION)

TABLE 169 FRANCE DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 170 FRANCE DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 ASP

TABLE 171 FRANCE DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (UNITS)

TABLE 172 FRANCE LIPID PANEL TESTING MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)

TABLE 173 FRANCE LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 174 FRANCE HYPERLIPIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 175 FRANCE HYPERTRIGLYCERIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 176 FRANCE ATHEROSCLEROSIS IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 177 FRANCE FAMILIAL HYPERCHOLESTEROLEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 178 FRANCE HYPO LIPOPROTEINAMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 179 FRANCE TANGIER DISEASE IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 180 FRANCE LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 181 FRANCE HOSPITAL IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 182 FRANCE PRIVATE IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 183 FRANCE PUBLIC IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 184 FRANCE HOSPITAL IN LIPID PANEL TESTING MARKET, BY TIER, 2021-2030 (USD MILLION)

TABLE 185 FRANCE TIER 1 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 186 FRANCE TIER 2 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 187 FRANCE TIER 3 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 188 FRANCE DIAGNOSTIC CLINICS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 189 FRANCE SPECIALTY CLINICS AND PHYSICIAN OFFICES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 190 FRANCE REFERENCE LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 191 FRANCE AMBULATORY SURGICAL CENTERS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 192 FRANCE PATHOLOGY LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 193 FRANCE ACADEMIC AND RESEARCH INSTITUTES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 194 FRANCE LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 195 FRANCE RETAIL PHARMACY IN LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 196 RUSSIA LIPID PANEL TESTING MARKET, BY PRODUCTS AND SERVICES, 2021-2030 (USD MILLION)

TABLE 197 RUSSIA SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)

TABLE 198 RUSSIA SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (PRICE PER TEST)

TABLE 199 RUSSIA SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (NUMBER OF TESTS)

TABLE 200 RUSSIA KITS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 201 RUSSIA STRIPS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 202 RUSSIA CONTROLS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 203 RUSSIA DEVICES IN LIPID PANEL TESTING MARKET, BY MODALITY, 2021-2030 (USD MILLION)

TABLE 204 RUSSIA DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 205 RUSSIA DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 ASP

TABLE 206 RUSSIA DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (UNITS)

TABLE 207 RUSSIA LIPID PANEL TESTING MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)

TABLE 208 RUSSIA LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 209 RUSSIA HYPERLIPIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 210 RUSSIA HYPERTRIGLYCERIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 211 RUSSIA ATHEROSCLEROSIS IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 212 RUSSIA FAMILIAL HYPERCHOLESTEROLEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 213 RUSSIA HYPO LIPOPROTEINAMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 214 RUSSIA TANGIER DISEASE IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 215 RUSSIA LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 216 RUSSIA HOSPITAL IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 217 RUSSIA PRIVATE IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 218 RUSSIA PUBLIC IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 219 RUSSIA HOSPITAL IN LIPID PANEL TESTING MARKET, BY TIER, 2021-2030 (USD MILLION)

TABLE 220 RUSSIA TIER 1 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 221 RUSSIA TIER 2 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 222 RUSSIA TIER 3 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 223 RUSSIA DIAGNOSTIC CLINICS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 224 RUSSIA SPECIALTY CLINICS AND PHYSICIAN OFFICES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 225 RUSSIA REFERENCE LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 226 RUSSIA AMBULATORY SURGICAL CENTERS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 227 RUSSIA PATHOLOGY LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 228 RUSSIA ACADEMIC AND RESEARCH INSTITUTES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 229 RUSSIA LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 230 RUSSIA RETAIL PHARMACY IN LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 231 ITALY LIPID PANEL TESTING MARKET, BY PRODUCTS AND SERVICES, 2021-2030 (USD MILLION)

TABLE 232 ITALY SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)

TABLE 233 ITALY SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (PRICE PER TEST)

TABLE 234 ITALY SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (NUMBER OF TESTS)

TABLE 235 ITALY KITS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 236 ITALY STRIPS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 237 ITALY CONTROLS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 238 ITALY DEVICES IN LIPID PANEL TESTING MARKET, BY MODALITY, 2021-2030 (USD MILLION)

TABLE 239 ITALY DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 240 ITALY DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 ASP

TABLE 241 ITALY DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (UNITS)

TABLE 242 ITALY LIPID PANEL TESTING MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)

TABLE 243 ITALY LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 244 ITALY HYPERLIPIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 245 ITALY HYPERTRIGLYCERIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 246 ITALY ATHEROSCLEROSIS IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 247 ITALY FAMILIAL HYPERCHOLESTEROLEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 248 ITALY HYPO LIPOPROTEINAMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 249 ITALY TANGIER DISEASE IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 250 ITALY LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 251 ITALY HOSPITAL IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 252 ITALY PRIVATE IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 253 ITALY PUBLIC IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 254 ITALY HOSPITAL IN LIPID PANEL TESTING MARKET, BY TIER, 2021-2030 (USD MILLION)

TABLE 255 ITALY TIER 1 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 256 ITALY TIER 2 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 257 ITALY TIER 3 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 258 ITALY DIAGNOSTIC CLINICS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 259 ITALY SPECIALTY CLINICS AND PHYSICIAN OFFICES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 260 ITALY REFERENCE LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 261 ITALY AMBULATORY SURGICAL CENTERS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 262 ITALY PATHOLOGY LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 263 ITALY ACADEMIC AND RESEARCH INSTITUTES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 264 ITALY LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 265 ITALY RETAIL PHARMACY IN LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 266 SPAIN LIPID PANEL TESTING MARKET, BY PRODUCTS AND SERVICES, 2021-2030 (USD MILLION)

TABLE 267 SPAIN SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)

TABLE 268 SPAIN SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (PRICE PER TEST)

TABLE 269 SPAIN SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (NUMBER OF TESTS)

TABLE 270 SPAIN KITS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 271 SPAIN STRIPS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 272 SPAIN CONTROLS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 273 SPAIN DEVICES IN LIPID PANEL TESTING MARKET, BY MODALITY, 2021-2030 (USD MILLION)

TABLE 274 SPAIN DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 275 SPAIN DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 ASP

TABLE 276 SPAIN DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (UNITS)

TABLE 277 SPAIN LIPID PANEL TESTING MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)

TABLE 278 SPAIN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 279 SPAIN HYPERLIPIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 280 SPAIN HYPERTRIGLYCERIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 281 SPAIN ATHEROSCLEROSIS IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 282 SPAIN FAMILIAL HYPERCHOLESTEROLEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 283 SPAIN HYPO LIPOPROTEINAMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 284 SPAIN TANGIER DISEASE IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 285 SPAIN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 286 SPAIN HOSPITAL IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 287 SPAIN PRIVATE IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 288 SPAIN PUBLIC IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 289 SPAIN HOSPITAL IN LIPID PANEL TESTING MARKET, BY TIER, 2021-2030 (USD MILLION)

TABLE 290 SPAIN TIER 1 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 291 SPAIN TIER 2 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 292 SPAIN TIER 3 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 293 SPAIN DIAGNOSTIC CLINICS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 294 SPAIN SPECIALTY CLINICS AND PHYSICIAN OFFICES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 295 SPAIN REFERENCE LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 296 SPAIN AMBULATORY SURGICAL CENTERS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 297 SPAIN PATHOLOGY LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 298 SPAIN ACADEMIC AND RESEARCH INSTITUTES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 299 SPAIN LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 300 SPAIN RETAIL PHARMACY IN LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 301 TURKEY LIPID PANEL TESTING MARKET, BY PRODUCTS AND SERVICES, 2021-2030 (USD MILLION)

TABLE 302 TURKEY SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)

TABLE 303 TURKEY SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (PRICE PER TEST)

TABLE 304 TURKEY SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (NUMBER OF TESTS)

TABLE 305 TURKEY KITS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 306 TURKEY STRIPS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 307 TURKEY CONTROLS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 308 TURKEY DEVICES IN LIPID PANEL TESTING MARKET, BY MODALITY, 2021-2030 (USD MILLION)

TABLE 309 TURKEY DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 310 TURKEY DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 ASP

TABLE 311 TURKEY DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (UNITS)

TABLE 312 TURKEY LIPID PANEL TESTING MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)

TABLE 313 TURKEY LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 314 TURKEY HYPERLIPIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 315 TURKEY HYPERTRIGLYCERIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 316 TURKEY ATHEROSCLEROSIS IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 317 TURKEY FAMILIAL HYPERCHOLESTEROLEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 318 TURKEY HYPO LIPOPROTEINAMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 319 TURKEY TANGIER DISEASE IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 320 TURKEY LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 321 TURKEY HOSPITAL IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 322 TURKEY PRIVATE IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 323 TURKEY PUBLIC IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 324 TURKEY HOSPITAL IN LIPID PANEL TESTING MARKET, BY TIER, 2021-2030 (USD MILLION)

TABLE 325 TURKEY TIER 1 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 326 TURKEY TIER 2 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 327 TURKEY TIER 3 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 328 TURKEY DIAGNOSTIC CLINICS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 329 TURKEY SPECIALTY CLINICS AND PHYSICIAN OFFICES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 330 TURKEY REFERENCE LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 331 TURKEY AMBULATORY SURGICAL CENTERS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 332 TURKEY PATHOLOGY LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 333 TURKEY ACADEMIC AND RESEARCH INSTITUTES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 334 TURKEY LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 335 TURKEY RETAIL PHARMACY IN LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 336 NETHERLANDS LIPID PANEL TESTING MARKET, BY PRODUCTS AND SERVICES, 2021-2030 (USD MILLION)

TABLE 337 NETHERLANDS SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)

TABLE 338 NETHERLANDS SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (PRICE PER TEST)

TABLE 339 NETHERLANDS SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (NUMBER OF TESTS)

TABLE 340 NETHERLANDS KITS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 341 NETHERLANDS STRIPS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 342 NETHERLANDS CONTROLS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 343 NETHERLANDS DEVICES IN LIPID PANEL TESTING MARKET, BY MODALITY, 2021-2030 (USD MILLION)

TABLE 344 NETHERLANDS DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 345 NETHERLANDS DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 ASP

TABLE 346 NETHERLANDS DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (UNITS)

TABLE 347 NETHERLANDS LIPID PANEL TESTING MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)

TABLE 348 NETHERLANDS LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 349 NETHERLANDS HYPERLIPIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 350 NETHERLANDS HYPERTRIGLYCERIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 351 NETHERLANDS ATHEROSCLEROSIS IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 352 NETHERLANDS FAMILIAL HYPERCHOLESTEROLEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 353 NETHERLANDS HYPO LIPOPROTEINAMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 354 NETHERLANDS TANGIER DISEASE IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 355 NETHERLANDS LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 356 NETHERLANDS HOSPITAL IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 357 NETHERLANDS PRIVATE IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 358 NETHERLANDS PUBLIC IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 359 NETHERLANDS HOSPITAL IN LIPID PANEL TESTING MARKET, BY TIER, 2021-2030 (USD MILLION)

TABLE 360 NETHERLANDS TIER 1 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 361 NETHERLANDS TIER 2 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 362 NETHERLANDS TIER 3 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 363 NETHERLANDS DIAGNOSTIC CLINICS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 364 NETHERLANDS SPECIALTY CLINICS AND PHYSICIAN OFFICES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 365 NETHERLANDS REFERENCE LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 366 NETHERLANDS AMBULATORY SURGICAL CENTERS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 367 NETHERLANDS PATHOLOGY LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 368 NETHERLANDS ACADEMIC AND RESEARCH INSTITUTES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 369 NETHERLANDS LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 370 NETHERLANDS RETAIL PHARMACY IN LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 371 SWITZERLAND LIPID PANEL TESTING MARKET, BY PRODUCTS AND SERVICES, 2021-2030 (USD MILLION)

TABLE 372 SWITZERLAND SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)

TABLE 373 SWITZERLAND SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (PRICE PER TEST)

TABLE 374 SWITZERLAND SERVICES IN LIPID PANEL TESTING MARKET, BY TEST TYPE, 2021-2030 (NUMBER OF TESTS)

TABLE 375 SWITZERLAND KITS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 376 SWITZERLAND STRIPS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 377 SWITZERLAND CONTROLS IN LIPID PANEL TESTING MARKET, BY PRODUCT, 2021-2030 (USD MILLION)

TABLE 378 SWITZERLAND DEVICES IN LIPID PANEL TESTING MARKET, BY MODALITY, 2021-2030 (USD MILLION)

TABLE 379 SWITZERLAND DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 380 SWITZERLAND DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 ASP

TABLE 381 SWITZERLAND DEVICES IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (UNITS)

TABLE 382 SWITZERLAND LIPID PANEL TESTING MARKET, BY PRESCRIPTION MODE, 2021-2030 (USD MILLION)

TABLE 383 SWITZERLAND LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 384 SWITZERLAND HYPERLIPIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 385 SWITZERLAND HYPERTRIGLYCERIDEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 386 SWITZERLAND ATHEROSCLEROSIS IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 387 SWITZERLAND FAMILIAL HYPERCHOLESTEROLEMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 388 SWITZERLAND HYPO LIPOPROTEINAMIA IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 389 SWITZERLAND TANGIER DISEASE IN LIPID PANEL TESTING MARKET, BY APPLICATION, 2021-2030 (USD MILLION)

TABLE 390 SWITZERLAND LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 391 SWITZERLAND HOSPITAL IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 392 SWITZERLAND PRIVATE IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 393 SWITZERLAND PUBLIC IN LIPID PANEL TESTING MARKET, BY TYPE, 2021-2030 (USD MILLION)

TABLE 394 SWITZERLAND HOSPITAL IN LIPID PANEL TESTING MARKET, BY TIER, 2021-2030 (USD MILLION)

TABLE 395 SWITZERLAND TIER 1 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 396 SWITZERLAND TIER 2 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 397 SWITZERLAND TIER 3 IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 398 SWITZERLAND DIAGNOSTIC CLINICS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 399 SWITZERLAND SPECIALTY CLINICS AND PHYSICIAN OFFICES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 400 SWITZERLAND REFERENCE LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 401 SWITZERLAND AMBULATORY SURGICAL CENTERS IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 402 SWITZERLAND PATHOLOGY LABORATORIES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 403 SWITZERLAND ACADEMIC AND RESEARCH INSTITUTES IN LIPID PANEL TESTING MARKET, BY END USER, 2021-2030 (USD MILLION)

TABLE 404 SWITZERLAND LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 405 SWITZERLAND RETAIL PHARMACY IN LIPID PANEL TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)

TABLE 406 REST OF EUROPE LIPID PANEL TESTING MARKET, BY PRODUCTS AND SERVICES, 2021-2030 (USD MILLION)

그림 목록

FIGURE 1 EUROPE LIPID PANEL TESTING MARKET: SEGMENTATION

FIGURE 2 EUROPE LIPID PANEL TESTING MARKET: DATA TRIANGULATION

FIGURE 3 EUROPE LIPID PANEL TESTING MARKET: DROC ANALYSIS

FIGURE 4 EUROPE LIPID PANEL TESTING MARKET: EUROPE VS REGIONAL MARKET ANALYSIS

FIGURE 5 EUROPE LIPID PANEL TESTING MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 EUROPE LIPID PANEL TESTING MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 EUROPE LIPID PANEL TESTING MARKET: DBMR MARKET POSITION GRID

FIGURE 8 EUROPE LIPID PANEL TESTING MARKET: MARKET TESTING TYPE COVERAGE GRID

FIGURE 9 EUROPE LIPID PANEL TESTING MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 EUROPE LIPID PANEL TESTING MARKET: SEGMENTATION

FIGURE 11 THE INCREASING PREVALENCE OF CHRONIC DISEASES IS EXPECTED TO DRIVE THE EUROPE LIPID PANEL TESTING MARKET IN THE FORECAST PERIOD

FIGURE 12 THE PRODUCTS & SERVICES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE LIPID PANEL TESTING MARKET IN 2023 & 2030

FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE EUROPE LIPID PANEL TESTING MARKET

FIGURE 14 EUROPE LIPID PANEL TESTING MARKET: BY PRODUCTS & SERVICES, 2022

FIGURE 15 EUROPE LIPID PANEL TESTING MARKET: BY PRODUCTS & SERVICES, 2023-2030 (USD MILLION)

FIGURE 16 EUROPE LIPID PANEL TESTING MARKET: BY PRODUCTS & SERVICES, CAGR (2023-2030)

FIGURE 17 EUROPE LIPID PANEL TESTING MARKET: BY PRODUCTS & SERVICES, LIFELINE CURVE

FIGURE 18 EUROPE LIPID PANEL TESTING MARKET: BY PRECRIPTION MODE, 2022

FIGURE 19 EUROPE LIPID PANEL TESTING MARKET: BY PRECRIPTION MODE, 2023-2030 (USD MILLION)

FIGURE 20 EUROPE LIPID PANEL TESTING MARKET: BY PRECRIPTION MODE, CAGR (2023-2030)

FIGURE 21 EUROPE LIPID PANEL TESTING MARKET: BY PRECRIPTION MODE, LIFELINE CURVE

FIGURE 22 EUROPE LIPID PANEL TESTING MARKET: BY APPLICATION, 2022

FIGURE 23 EUROPE LIPID PANEL TESTING MARKET: BY APPLICATION, 2023-2030 (USD MILLION)

FIGURE 24 EUROPE LIPID PANEL TESTING MARKET: BY APPLICATION, CAGR (2023-2030)

FIGURE 25 EUROPE LIPID PANEL TESTING MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 26 EUROPE LIPID PANEL TESTING MARKET: BY END USER, 2022

FIGURE 27 EUROPE LIPID PANEL TESTING MARKET: BY END USER, 2023-2030 (USD MILLION)

FIGURE 28 EUROPE LIPID PANEL TESTING MARKET: BY END USER, CAGR (2023-2030)

FIGURE 29 EUROPE LIPID PANEL TESTING MARKET: BY END USER, LIFELINE CURVE

FIGURE 30 EUROPE LIPID PANEL TESTING MARKET: BY DISTRIBUTION CHANNEL, 2022

FIGURE 31 EUROPE LIPID PANEL TESTING MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)

FIGURE 32 EUROPE LIPID PANEL TESTING MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)

FIGURE 33 EUROPE LIPID PANEL TESTING MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 34 EUROPE LIPID PANEL TESTING MARKET: SNAPSHOT (2022)

FIGURE 35 EUROPE LIPID PANEL TESTING MARKET: BY COUNTRY (2022)

FIGURE 36 EUROPE LIPID PANEL TESTING MARKET: BY COUNTRY (2023 & 2030)

FIGURE 37 EUROPE LIPID PANEL TESTING MARKET: BY COUNTRY (2022 & 2030)

FIGURE 38 EUROPE LIPID PANEL TESTING MARKET: PRODUCTS & SERVICES (2023-2030)

FIGURE 39 EUROPE LIPID PANEL TESTING MARKET: COMPANY SHARE 2022 (%)

자세한 정보 보기 Right Arrow

연구 방법론

데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.

DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.

사용자 정의 가능

Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.

자주 묻는 질문

The Europe Lipid Panel Testing Market is projected to grow at a CAGR of 6.7% during the forecast period by 2030.
The future market value of the Europe Lipid Panel Testing Market is expected to reach USD 4,378.47 million by 2030.
The major players in the Europe Lipid Panel Testing Market are Nova Biomedical, Spark Diagnostics Pvt. Ltd., Everlywell, Inc., HORIBA Medical, Abbott, F. Hoffmann-La Roche Ltd., SD Biosensor, INC., Elitech Group, Randox Laboratories Ltd., Diatron, Siemens Healthcare GmbH, etc.
The countries covered in the Europe Lipid Panel Testing Market are Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe.